M. Attal, J. L. Harousseau, A. M. Stoppa, J. J. Sotto, J. G. Fuzibet et al., A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma, New England Journal of Medicine, vol.335, issue.2, pp.91-97, 1996.
DOI : 10.1056/NEJM199607113350204

S. Bauer, V. Groh, J. Wu, A. Steinle, J. H. Phillips et al., Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA, Science, vol.285, issue.5428, pp.727-729, 1999.
DOI : 10.1126/science.285.5428.727

M. Brandes, K. Willimann, and B. Moser, Professional Antigen-Presentation Function by Human gd T Cells, Science, vol.309, issue.5732, pp.264-268, 2005.
DOI : 10.1126/science.1110267

P. Brossart, A. Schneider, P. Dill, T. Schammann, F. Grunebach et al., The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes, Cancer Research, vol.61, pp.6846-6850, 2001.

J. F. Bukowski, C. T. Morita, Y. Tanaka, B. R. Bloom, M. B. Brenner et al., V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer, Journal of Immunology, vol.154, pp.998-1006, 1995.

J. P. Chute, Stem cell homing, Current Opinion in Hematology, vol.13, issue.6, pp.399-406, 2006.
DOI : 10.1097/01.moh.0000245698.62511.3d

A. Cignetti, A. Vallario, A. Follenzi, P. Circosta, A. Capaldi et al., Lentiviral Transduction of Primary Myeloma Cells with CD80 and CD154 Generates Antimyeloma Effector T Cells, Human Gene Therapy, vol.16, issue.4, pp.445-456, 2005.
DOI : 10.1089/hum.2005.16.445

M. Condomines, D. Hose, P. Raynaud, M. Hundemer, J. De-vos et al., Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis, The Journal of Immunology, vol.178, issue.5, pp.3307-3315, 2007.
DOI : 10.4049/jimmunol.178.5.3307
URL : https://hal.archives-ouvertes.fr/inserm-00130292

M. Condomines, P. Quittet, Z. Y. Lu, L. Nadal, P. Latry et al., Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor, The Journal of Immunology, vol.176, issue.11, pp.6631-6639, 2006.
DOI : 10.4049/jimmunol.176.11.6631
URL : https://hal.archives-ouvertes.fr/inserm-00131765

P. Constant, F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo et al., Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands, Science, vol.264, issue.5156, pp.267-270, 1994.
DOI : 10.1126/science.8146660

V. Costes, V. Magen, E. Legouffe, L. Durand, P. Baldet et al., The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens, Human Pathology, vol.30, issue.12, pp.1405-1411, 1999.
DOI : 10.1016/S0046-8177(99)90160-0

H. Das, L. Wang, A. Kamath, and J. F. Bukowski, Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates, Blood, vol.98, issue.5, pp.1616-1618, 2001.
DOI : 10.1182/blood.V98.5.1616

F. Dieli, F. Poccia, M. Lipp, G. Sireci, N. Caccamo et al., Differentiation of Effector/Memory V??2 T Cells and Migratory Routes in Lymph Nodes or Inflammatory Sites, The Journal of Experimental Medicine, vol.157, issue.3, pp.391-397, 2003.
DOI : 10.1086/345766

E. Espinosa, C. Belmant, F. Pont, B. Luciani, R. Poupot et al., Chemical Synthesis and Biological Activity of Bromohydrin Pyrophosphate, a Potent Stimulator of Human gamma delta T Cells, Journal of Biological Chemistry, vol.276, issue.21, pp.18337-18344, 2001.
DOI : 10.1074/jbc.M100495200

Y. Gazitt and C. Akay, Mobilization of Myeloma Cells Involves SDF-1/CXCR4 Signaling and Downregulation of VLA-4, Stem Cells, vol.29, issue.1, pp.65-73, 2004.
DOI : 10.1634/stemcells.22-1-65

S. Girlanda, C. Fortis, D. Belloni, E. Ferrero, P. Ticozzi et al., MICA Expressed by Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance Plasma Cells Costimulates Pamidronate-Activated ???? Lymphocytes, Cancer Research, vol.65, issue.16, pp.7502-7508, 2005.
DOI : 10.1158/0008-5472.CAN-05-0731

H. J. Gober, M. Kistowska, L. Angman, P. Jeno, L. Mori et al., Human T Cell Receptor ???? Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells, The Journal of Experimental Medicine, vol.263, issue.2, pp.163-168, 2003.
DOI : 10.1038/sj.onc.1203002

T. Goto, S. J. Kennel, M. Abe, M. Takishita, M. Kosaka et al., A novel membrane antigen selectively expressed on terminally differentiated human B cells, Blood, vol.84, pp.1922-1930, 1994.

Z. J. Gu, J. De-vos, C. Rebouissou, M. Jourdan, X. G. Zhang et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-197, 2000.
DOI : 10.1038/sj.leu.2401632

F. Halary, M. A. Peyrat, E. Champagne, M. Lopez-botet, A. Moretta et al., Control of self-reactive cytotoxic T lymphocytes expressing ???? T cell receptors by natural killer inhibitory receptors, European Journal of Immunology, vol.365, issue.11, pp.2812-2821, 1997.
DOI : 10.1002/eji.1830271111

A. C. Hayday, ???? Cells: A Right Time and a Right Place for a Conserved Third Way of Protection, Annual Review of Immunology, vol.18, issue.1, pp.975-1026, 2000.
DOI : 10.1146/annurev.immunol.18.1.975

M. Hundemer, S. Schmidt, M. Condomines, A. Lupu, D. Hose et al., Identification of a new HLA-A2???restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma, Experimental Hematology, vol.34, issue.4, pp.486-496, 2006.
DOI : 10.1016/j.exphem.2006.01.008
URL : https://hal.archives-ouvertes.fr/inserm-00131759

M. Jourdan, M. Ferlin, E. Legouffe, M. Horvathova, J. Liautard et al., The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells, British Journal of Haematology, vol.83, issue.4, pp.637-646, 1998.
DOI : 10.1046/j.1365-2141.1996.d01-1811.x

Y. Kato, Y. Tanaka, H. Tanaka, S. Yamashita, and N. Minato, Requirement of Species-Specific Interactions for the Activation of Human ???? T Cells by Pamidronate, The Journal of Immunology, vol.170, issue.7, pp.3608-3613, 2003.
DOI : 10.4049/jimmunol.170.7.3608

M. Katsuta, Y. Takigawa, M. Kimishima, M. Inaoka, R. Takahashi et al., NK Cells and ????+ T Cells Are Phenotypically and Functionally Defective due to Preferential Apoptosis in Patients with Atopic Dermatitis, The Journal of Immunology, vol.176, issue.12, pp.7736-7744, 2006.
DOI : 10.4049/jimmunol.176.12.7736

H. Kobayashi, Y. Tanaka, J. Yagi, Y. Osaka, H. Nakazawa et al., Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study, Cancer Immunology, Immunotherapy, vol.173, issue.11, pp.469-476, 2007.
DOI : 10.1007/s00262-006-0199-6

V. Kunzmann, E. Bauer, J. Feurle, F. Weissinger, H. P. Tony et al., Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma, Blood, vol.96, pp.384-392, 2000.

Z. Y. Lu, M. Condomines, K. Tarte, L. Nadal, M. C. Delteil et al., B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro, Experimental Hematology, vol.35, issue.3, pp.443-453, 2007.
DOI : 10.1016/j.exphem.2006.11.002
URL : https://hal.archives-ouvertes.fr/inserm-00132799

S. Mariani, M. Muraro, F. Pantaleoni, F. Fiore, B. Nuschak et al., Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma, Leukemia, vol.19, pp.664-670, 2005.

F. Miyagawa, Y. Tanaka, S. Yamashita, and N. Minato, Essential Requirement of Antigen Presentation by Monocyte Lineage Cells for the Activation of Primary Human ???? T Cells by Aminobisphosphonate Antigen, The Journal of Immunology, vol.166, issue.9, pp.5508-5514, 2001.
DOI : 10.4049/jimmunol.166.9.5508

C. Pellat-deceunynck, M. P. Mellerin, N. Labarriere, G. Jego, A. Moreau-aubry et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells, European Journal of Immunology, vol.30, issue.3, pp.803-809, 2000.
DOI : 10.1002/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P

F. Re, A. Donnini, B. Bartozzi, G. Bernardini, and M. Provinciali, Circulating gammadelta T cells in young/adult and old patients with cutaneous primary melanoma, Immunity & Ageing, vol.2, issue.1, pp.2-6, 2005.
DOI : 10.1186/1742-4933-2-2

C. Rebouissou, J. Wijdenes, P. Autissier, K. Tarte, V. Costes et al., A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma, Blood, vol.91, pp.4727-4737, 1998.

B. Rincon-orozco, V. Kunzmann, P. Wrobel, D. Kabelitz, A. Steinle et al., Activation of V??9V??2 T Cells by NKG2D, The Journal of Immunology, vol.175, issue.4, pp.2144-2151, 2005.
DOI : 10.4049/jimmunol.175.4.2144

E. Scotet, L. O. Martinez, E. Grant, R. Barbaras, P. Jeno et al., Tumor Recognition following V??9V??2 T Cell Receptor Interactions with a Surface F1-ATPase-Related Structure and Apolipoprotein A-I, Immunity, vol.22, issue.1, pp.71-80, 2005.
DOI : 10.1016/j.immuni.2004.11.012

H. Sicard, S. Ingoure, B. Luciani, C. Serraz, J. J. Fournie et al., In Vivo Immunomanipulation of V??9V??2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model, The Journal of Immunology, vol.175, issue.8, pp.5471-5480, 2005.
DOI : 10.4049/jimmunol.175.8.5471

R. X. Sun, Z. Y. Lu, J. Wijdenes, J. Brochier, C. Hertog et al., Large scale and clinical grade purification of syndecan-1+ malignant plasma cells, Journal of Immunological Methods, vol.205, issue.1, pp.73-79, 1997.
DOI : 10.1016/S0022-1759(97)00056-2

Y. Tanaka, C. T. Morita, E. Nieves, M. B. Brenner, and B. R. Bloom, Natural and synthetic non-peptide antigens recognized by human ???? T cells, Nature, vol.375, issue.6527, pp.155-158, 1995.
DOI : 10.1038/375155a0

K. Tarte, X. G. Zhang, E. Legouffe, C. Hertog, M. Mehtali et al., Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, Journal of Immunology, vol.163, pp.514-524, 1999.

K. Thompson, J. Rojas-navea, and M. J. Rogers, Alkylamines cause V??9V??2 T-cell activation and proliferation by inhibiting the mevalonate pathway, Blood, vol.107, issue.2, pp.651-654, 2006.
DOI : 10.1182/blood-2005-03-1025

N. Van-baren, F. Brasseur, D. Godelaine, G. Hames, A. Ferrant et al., Genes encoding tumor-specific antigens are expressed in human myeloma cells, Blood, vol.94, pp.1156-1164, 1999.

E. Viey, G. Fromont, B. Escudier, Y. Morel, S. Da-rocha et al., Phosphostim-Activated ???? T Cells Kill Autologous Metastatic Renal Cell Carcinoma, The Journal of Immunology, vol.174, issue.3, pp.1338-1347, 2005.
DOI : 10.4049/jimmunol.174.3.1338

M. Von-lilienfeld-toal, J. Nattermann, G. Feldmann, E. Sievers, S. Frank et al., Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells, Clinical and Experimental Immunology, vol.167, issue.3, pp.528-533, 2006.
DOI : 10.1182/blood-2004-04-1422

P. Wang and M. Malkovsky, Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9/V delta 2 T cells, Molecular Medicine, vol.6, pp.196-207, 2000.

J. Wijdenes, W. C. Vooijs, C. Clement, J. Post, F. Morard et al., A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1, British Journal of Haematology, vol.94, issue.2, pp.318-323, 1996.
DOI : 10.1046/j.1365-2141.1996.d01-1811.x